復宏漢霖(02696):HLX15-SC (重組抗CD38全人單克隆抗體注射液-皮下注射)用於多發性骨髓瘤治療的1期臨牀試驗申請獲美國FDA批准

Post Content

Read More 

You may also like...

Generated by Feedzy